Development and preclinical assessment of a first-in-class small molecule inhibitor of FLIP

被引：0
作者：
Majkut, Joanna
Higgins, Catherine
Fox, Jennifer
Fiedler, Greti E.
Harrison, Timothy
Longley, Daniel B.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
基金：
英国惠康基金;
关键词：
D O I：
10.1158/1538-7445.AM2017-LB-305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-305
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Unbiased molecular dynamics simulation of a first-in-class small molecule inhibitor binds to oncostatin M
    Du, Qingqing
    Tu, Gao
    Qian, Yan
    Yang, Jingyi
    Yao, Xiaojun
    Xue, Weiwei
    COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 155
  • [12] Discovery of First-in-Class Small Molecule Adhesion GPCR Modulators
    Vizurraga, Alexander
    Yeung, Jennifer
    Tall, Gregory
    FASEB JOURNAL, 2020, 34
  • [13] PRECLINICAL DEVELOPMENT OF A FIRST-IN-CLASS FUSION INHIBITOR AGAINST DIVERSE AND MULTIDRUG-RESISTANT HCV STRAINS
    Ma, Christopher
    Imamura, Michio
    Rolt, Adam
    Xu, Xin
    Wang, Amy Q.
    Le, Derek
    Uchida, Takuro
    Osawa, Mitsutaka
    Teraoka, Yuji
    Li, Kelin
    Hu, Xin
    Park, Seung Bum
    Chalasani, Nishanth
    Talley, Daniel
    Dulcey, Andres E.
    Southall, Noel
    Marugan, Juan J.
    Hu, Zongyi
    Chayama, Kazuaki
    Frankowski, Kevin J.
    Liang, T. Jake
    HEPATOLOGY, 2019, 70 : 986A - 986A
  • [14] Mavacamten (CAMZYOS) First-in-Class Small-Molecule Myosin Inhibitor for Treatment of Obstructive Hypertrophic Cardiomyopathy
    O'Malley, Patricia Anne
    CLINICAL NURSE SPECIALIST, 2024, 38 (03) : 119 - 121
  • [15] The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
    Claudio Festuccia
    Andrea Mancini
    Alessandro Colapietro
    Giovanni Luca Gravina
    Flora Vitale
    Francesco Marampon
    Simona Delle Monache
    Simona Pompili
    Loredana Cristiano
    Antonella Vetuschi
    Vincenzo Tombolini
    Yi Chen
    Thomas Mehrling
    Journal of Hematology & Oncology, 11
  • [16] The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma
    Festuccia, Claudio
    Mancini, Andrea
    Colapietro, Alessandro
    Gravina, Giovanni Luca
    Vitale, Flora
    Marampon, Francesco
    Delle Monache, Simona
    Pompili, Simona
    Cristiano, Loredana
    Vetuschi, Antonella
    Tombolini, Vincenzo
    Chen, Yi
    Mehrling, Thomas
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [17] Preclinical and first-in human development of SGM-1019, a first-in-class novel small molecule modulator of inflammasome activity for the treatment of nonalcoholic steatohepatitis (NASH)
    Dabbagh, K.
    Dodson, G. Steven
    Yamamoto, L.
    Baeza-Raja, B.
    Goodyear, A. W.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S60 - S60
  • [18] The Anticancer Activity of a First-in-class Small-molecule Targeting PCNA
    Gu, Long
    Lingeman, Robert
    Yakushijin, Fumiko
    Sun, Emily
    Cui, Qi
    Chao, Jianfei
    Hu, Weidong
    Li, Hongzhi
    Hickey, Robert J.
    Stark, Jeremy M.
    Yuan, Yate-Ching
    Chen, Yuan
    Vonderfecht, Steven L.
    Synold, Timothy W.
    Shi, Yanhong
    Reckamp, Karen L.
    Horne, David
    Malkas, Linda H.
    CLINICAL CANCER RESEARCH, 2018, 24 (23) : 6053 - 6065
  • [19] DEVELOPMENT OF A NOVEL FIRST-IN-CLASS ORAL INHIBITOR OF THE NOTCH PATHWAY
    Lehal, R.
    Frismantas, V.
    Reinmuller, V.
    Turcatti, G.
    Bourquin, J. P.
    Radtke, F.
    HAEMATOLOGICA, 2016, 101 : 29 - 29
  • [20] RRx-001, a first-in-class small molecule inhibitor of MYC and a downregulator of CD47, is an "erythrophagoimmunotherapeutic"
    Oronsky, Bryan
    Carter, Corey A.
    Caroen, Scott
    Scribner, Curtis
    Oronsky, Arnold
    Reid, Tony R.
    ONCOIMMUNOLOGY, 2020, 9 (01):
12345